Loading…
Reported covered position: CHIEF OF STAFF
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2019 · second_quarter · Q2
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Source: Senate LDA
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
H.R. 1406, Fairness to Pet Owners Act 2011 H.R. 1513, Great Ape Protection Act
E. coli Vaccine for Animals ELDU Ban on Cephalosporin H.R. 1406, Fairness to Pet Owners Act 2011
E. coli Vaccine for Animals ELDU Ban on Cephalosporin H.R. 1406, Fairness to Pet Owners Act 2011
H.R. 1406, Fairness to Pet Owners Act 2011 H.R. 1513, Great Ape Protection Act
Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1671, The Foreign Earnings Reinvestment Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1671, The Foreign Earnings Reinvestment Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1671, The Foreign Earnings Reinvestment Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations.
Client: PFIZER INC. · Firm: PFIZER INC.
Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1671, The Foreign Earnings Reinvestment Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation The Food, Drug and Cosmetic Globalization Act Dextromethorphan Distribution Dextromethorphan Abuse Reduction H.R. 741 - Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373 - Fair Prescription Drug Competition Act, 2011
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation The Food, Drug and Cosmetic Globalization Act Dextromethorphan Distribution Dextromethorphan Abuse Reduction H.R. 741 - Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373 - Fair Prescription Drug Competition Act, 2011
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Protecting Consumer Access to Generic Drugs Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009
Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
National Quality Cancer Care Demonstration Project Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009
2019 · first_quarter · 1A
FY 2020 Appropriation Bills
Creates Act
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · first_quarter · Q1
FY 2020 Appropriation Bills
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements
Creates Act
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · 4A
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Medicare Part D Coverage Gap
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Creates Act Transferable exclusivity
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · 3A
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Creates Act Transferable exclusivity
Prescription Drug Abuse
Medicare Part D Coverage Gap
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
2018 · fourth_quarter · Q4
Creates Act Transferable exclusivity
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
2018 · third_quarter · Q3
Prescription Drug Abuse
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Creates Act Transferable exclusivity
2018 · second_quarter · 2A
Medicare Part D Coverage Gap Biosimilar pass-through
Comprehensive Corporate Tax Reform
Creates Act Patent Settlements Transferable exclusivity
2018 · second_quarter · 2A
Comprehensive Corporate Tax Reform
Creates Act Patent Settlements Transferable exclusivity
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
2018 · second_quarter · Q2
Medicare Part D Coverage Gap Biosimilar pass-through
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Comprehensive Corporate Tax Reform
2018 · first_quarter · Q1
Medicare Part D Coverage Gap Biosimilar pass-through
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease
Creates Act Patent Settlements Transferable exclusivity
2018 · first_quarter · RA
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
2017 · third_quarter · 3A
Drug Pricing User Fees Biosimilars Reimbursement Antibiotic Resistance Drug Shortages Reimbursement for products treating Sickle Cell Disease
Medicare Rebates/Medicare Part D/C Medicare Part B CMMI Demo Non-Interference Re-Importation
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2017 · fourth_quarter · Q4
2018 FDA & Labor/HHS Appropriation Bills
Medicare Part D Medicare Part B CMMI Demo Medicare Part B Reimbursement Non-Interference Importation
Prescription Drug Abuse
2017 · third_quarter · Q3
Medicare Rebates/Medicare Part D/C Medicare Part B CMMI Demo Non-Interference Re-Importation
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Drug Pricing User Fees Biosimilars Reimbursement Antibiotic Resistance Drug Shortages Reimbursement for products treating Sickle Cell Disease
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2017 · first_quarter · 1A
Prescription Drug Abuse
Omnibus Appropriations Bill 2018 FDA & Labor/HHS Appropriation Bills
Medicare Rebates/Medicare Part D Medicare Part B CMMI Demo Non-Interference Re-Importation
2017 · second_quarter · Q2
Medicare Rebates/Medicare Part D Medicare Part B CMMI Demo Non-Interference Re-Importation Part A Reimbursement
2018 FDA & Labor/HHS Appropriation Bills
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
2017 · first_quarter · Q1
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Prescription Drug Abuse
Omnibus Appropriations Bill 2018 FDA & Labor/HHS Appropriation Bills
2016 · fourth_quarter · 4A
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo Re-importation
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy User Fees
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations Border Adjustable Tax
2016 · third_quarter · 3A
Omnibus Appropriations Bill 2017 FDA & Labor/HHS Appropriation Bills
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Issues Indonesia IP Issues Thailand IP Issues Korea Pricing Issues Saudia Arabia Pricing Issues United Nations Health Panel Privacy Shield G7/G20 APEC OECD
2016 · second_quarter · 2A
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions Section 385 Proposed Regulations
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
2016 · fourth_quarter · Q4
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo Re-importation
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations Border Adjustable Tax
2016 · second_quarter · 2A
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel Thermacare EU Privacy Shield G7/G20 APEC OECD
2016 · third_quarter · Q3
Omnibus Appropriations Bill 2017 FDA & Labor/HHS Appropriation Bills
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
2016 · second_quarter · Q2
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
2016 · first_quarter · Q1
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B Demonstration Proposal Medicare Part B CMMI Demo
2015 · fourth_quarter · Q4
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box Cadillac Tax Inversions
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Trade Adjustment Assistance United Nations Health Panel
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
2015 · third_quarter · 3A
FDA Funding 340B 21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box Cadillac Tax
2015 · second_quarter · 2A
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Vietnam Distribution Trade Adjustment Assistance
2015 · second_quarter · Q2
Patent Troll Legislation
FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative Senate Innovation Project
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Vietnam Distribution Trade Adjustment Assistance
2015 · first_quarter · Q1
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box
STOPPAct (Stop the Tampering of Prescription Pills)
2014 · third_quarter · Q3
Deferral Comprehensive Tax Reform Territorial Systems BudgetBase Erosion and Profit Shifting (BEPS)
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations 340B
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2014 · fourth_quarter · Q4
Health Care Reform FDA Appropriations HHS Appropriations Interior Appropriations 340B Antibiotics/Dormant Therapies Domestic Drug Pricing - General FDA Breakthrough Therapies 21st Century Cures Initiative
STOPPAct (Stop the Tampering of Prescription Pills)
Medicare Rebates/Medicare Part D Non- Interference SGR "Fix" Negotiations CMS Medicare Manual Changes
2014 · third_quarter · Q3
Deferral Comprehensive Tax Reform Territorial Systems BudgetBase Erosion and Profit Shifting (BEPS)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations 340B
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2014 · second_quarter · Q2
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Turkey Pricing/IP
Prescription Drug Abuse
2014 · first_quarter · Q1
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Minimum Tax Taxation or Intangible Income Budget Base Erosion and Profit Shifting (BEPS)
Patent Settlements Patent Troll Legislation CMS Rule Preventing Abuse of Cough Treatment Act
Opioid Abuse Prescription Drug Abuse
2013 · third_quarter · 3A
Certified Importer Program Supply Chain Issues
Patent Settlements Patent Reform Patent Troll Legislation
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues
2013 · second_quarter · 2A
Trans Pacific Partnership Negotiations India IP/Trade Issues
Opioid Abuse Prescription Drug Abuse
Patent Settlements Patent Reform Patent Troll Legislation
2013 · first_quarter · 1A
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
2013 · third_quarter · RA
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
2013 · fourth_quarter · 4A
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Minimum Tax Taxation or Intangible Income Budget
Patent Settlements Patent Troll Legislation
Health Care Reform FDA Funding Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Prescription Drug User Fee Act (PDUFA) ImplementationSequester of User Fee
2013 · third_quarter · 3A
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Patent Settlements Patent Reform Patent Troll Legislation
2013 · second_quarter · 2A
Opioid Abuse Prescription Drug Abuse
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
2013 · first_quarter · 1A
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
2013 · first_quarter · Q1
Certified Importer Program Supply Chain Issues
Opioid Abuse Prescription Drug Abuse
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
2013 · first_quarter · Q1
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 8, American Taxpayer Relief Act
Certified Importer Program Supply Chain Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
2012 · fourth_quarter · Q4
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Homeland Security and Defense Issues Surrounding Readiness for a Chemical Nerve Agent Attack or Industrial Accident.
H.R. 1406, Fairness to Pet Owners Act 2011 H.R. 1513, Great Ape Protection Act
2012 · third_quarter · Q3
E. coli Vaccine for Animals ELDU Ban on Cephalosporin H.R. 1406, Fairness to Pet Owners Act 2011
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction PSE Issues Supply Chain Issues Counterfeits
Homeland Security and Defense Issues Surrounding Readiness for a Chemical Nerve Agent Attack or Industrial Accident.
2012 · second_quarter · Q2
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011
2012 · first_quarter · 1A
Opioid Abuse Priscription Drug Abuse
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
2012 · first_quarter · Q1
Trans Pacific Partnership Negotiations
Opioid Abuse Priscription Drug Abuse
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
2011 · fourth_quarter · 4A
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits
Medicare Rebates/Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
2011 · third_quarter · 3A
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
2011 · second_quarter · 2A
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
2011 · first_quarter · 1A
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
Importation The Food, Drug and Cosmetic Globalization Act Dextromethorphan Distribution Dextromethorphan Abuse Reduction H.R. 741 - Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373 - Fair Prescription Drug Competition Act, 2011
2011 · fourth_quarter · Q4
Trans Pacific Partnership Negotiations
Medicare Rebates/Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
2011 · third_quarter · Q3
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
2011 · second_quarter · Q2
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Counterfeit Pharmaceuticals Expert Patent Courts Pilot Programs Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
2011 · first_quarter · Q1
Importation The Food, Drug and Cosmetic Globalization Act Dextromethorphan Distribution Dextromethorphan Abuse Reduction H.R. 741 - Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373 - Fair Prescription Drug Competition Act, 2011
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011
2010 · fourth_quarter · Q4
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
2010 · third_quarter · Q3
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
2010 · second_quarter · Q2
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
2010 · first_quarter · Q1
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
2009 · fourth_quarter · 4A
Wyeth Acquisition
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
2009 · third_quarter · 3A
H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Deferral for active-financing income- extension Tax Treaties - France, New Zealand, Malta
H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance
2009 · first_quarter · 1A
S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009
Environmental issues related to pharmaceutical manufacturing
S. 515, Patent Reform Act of 2009 S. 299, Expert Patent Courts Pilot Program Act, 1/09 S. 369, Preserve Access to Affordable Generics, 2/09 S. 515 Patent Reform Act, 3/09 S.610, Patent Reform Act, 3/09 HR 1260, Patent Reform Act, 3/09 HR 1706, Protecting Consumer Access to Generics Drug Act, 3/09 HR 1548, Pathway for Biosimilars Act
2009 · fourth_quarter · Q4
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Wyeth Acquisition
2009 · fourth_quarter · Q4
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance
2009 · third_quarter · Q3
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Deferral for active-financing income- extension Tax Treaties - France, New Zealand, Malta
2009 · first_quarter · 1A
S. 515, Patent Reform Act of 2009 S. 299, Expert Patent Courts Pilot Program Act, 1/09 S. 369, Preserve Access to Affordable Generics, 2/09 S. 515 Patent Reform Act, 3/09 S.610, Patent Reform Act, 3/09 HR 1260, Patent Reform Act, 3/09 HR 1706, Protecting Consumer Access to Generics Drug Act, 3/09 HR 1548, Pathway for Biosimilars Act
S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09
2009 · first_quarter · Q1
S. 515, Patent Reform Act of 2009 S. 299, Expert Patent Courts Pilot Program Act, 1/09 S. 369, Preserve Access to Affordable Generics, 2/09 S. 515 Patent Reform Act, 3/09 S.610, Patent Reform Act, 3/09 HR 1260, Patent Reform Act, 3/09 HR 1706, Protecting Consumer Access to Generics Drug Act, 3/09 HR 1548, Pathway for Biosimilars Act
Environmental issues related to pharmaceutical manufacturing
Smoking Cessation Coverage VA Drug Coverage
2009 · second_quarter · Q2
H.R. 1 - American Recovery and Reinvestment Act of 2009 H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Repatriation
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics
2009 · first_quarter · Q1
S. 515, Patent Reform Act of 2009 S. 299, Expert Patent Courts Pilot Program Act, 1/09 S. 369, Preserve Access to Affordable Generics, 2/09 S. 515 Patent Reform Act, 3/09 S.610, Patent Reform Act, 3/09 HR 1260, Patent Reform Act, 3/09 HR 1706, Protecting Consumer Access to Generics Drug Act, 3/09 HR 1548, Pathway for Biosimilars Act
S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09
2008 · fourth_quarter · Q4
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008
HR. 6432 - Animal Drug User Fee Amendments of 2008. HR. 3161 - Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08
2008 · third_quarter · 3A
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008
2008 · third_quarter · Q3
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008
2008 · second_quarter · Q2
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008
2008 · first_quarter · Q1
HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act
2007 · year_end · YY
HR. 2138, R&D tax credit extension S. 41, R&D tax credit extension S. 41, S. 2209, HR. 1712, R&E tax credit Tax treaties with Belgium, Denmark, Finland and Germany
HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation
S 3807, Enhancing Drug Safety and Innovation Act of 2006, drug safety, DTC
Medicare Part D Coverage Gap
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Medicare Part D Coverage Gap
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
Prescription Drug Abuse
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Prescription Drug Abuse
Medicare Part D Coverage Gap Biosimilar pass-through
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Creates Act Patent Settlements Transferable exclusivity
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance Drug Shortages Reimbursement for products treating Sickle Cell Disease
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Drug Pricing User Fees Biosimilars Reimbursement
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Drug Pricing User Fees Biosimilars Reimbursement Antibiotic Resistance
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Drug Pricing User Fees Biosimilars Reimbursement
Medicare Rebates/Medicare Part D Medicare Part B CMMI Demo Non-Interference Re-Importation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Prescription Drug Abuse
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel Thermacare EU Privacy Shield G7/G20 APEC OECD
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy User Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions Section 385 Proposed Regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Issues Indonesia IP Issues Thailand IP Issues Korea Pricing Issues Saudia Arabia Pricing Issues United Nations Health Panel Privacy Shield G7/G20 APEC OECD
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions Section 385 Proposed Regulations
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel Thermacare EU Privacy Shield G7/G20 APEC OECD
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Patent Troll Legislation
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Trade Adjustment Assistance
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative Senate Innovation Project
Patent Troll Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Patent Troll Legislation
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Venezuela Pricing Issues WTO Trade Facilitation Agreement (TFA) APEC Leaders Meeting Vietnam Distribution Israel Pricing
FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Patent Troll Legislation
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia IP Taiwan Pricing Issues Algeria Pricing Issues Venezuela Pricing Issues WTO Trade Facilitation Agreement (TFA) APEC Leaders Meeting
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Minimum Tax Taxation or Intangible Income Budget Base Erosion and Profit Shifting (BEPS)
Patent Settlements Patent Troll Legislation CMS Rule Preventing Abuse of Cough Treatment Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation Budget Control Act/Sequester User FeesHHS Appropriations Interior Appropriations
Certified Importer Program Supply Chain Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Thailand Pricing Taiwan Pricing Turkey Pricing/IP
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Certified Importer Program Supply Chain Issues
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Opioid Abuse Prescription Drug Abuse
Certified Importer Program Supply Chain Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Thailand Pricing Taiwan Pricing
Certified Importer Program Supply Chain Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Certified Importer Program Supply Chain Issues
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Trans Pacific Partnership Negotiations India IP/Trade Issues
Patent Settlements Patent Reform Patent Troll Legislation
Certified Importer Program Supply Chain Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Opioid Abuse Prescription Drug Abuse
Certified Importer Program Supply Chain Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Opioid Abuse Prescription Drug Abuse
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction PSE Issues Supply Chain Issues Counterfeits
Counterfeit Pharmaceuticals Patent Settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Counterfeit Pharmaceuticals Patent Settlements
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Trans Pacific Partnership Negotiations
Opioid Abuse Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Opioid Abuse Prescription Drug Abuse
Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 2280, The Offshoring Prevention Act H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1671, The Foreign Earnings Reinvestment Act S. 45, The Offshoring Prevention Act S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits
E. coli Vaccine for Animals ELDU Ban on Cephalosporin H.R. 1406, Fairness to Pet Owners Act 2011
Trans Pacific Partnership Negotiations
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Trans Pacific Partnership Negotiations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Trans Pacific Partnership Negotiations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
Counterfeit Pharmaceuticals Expert Patent Courts Pilot Programs Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account H.R. 741, Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373, Fair Prescription Drug Competition Act, 2011
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance
H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act
H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act
Wyeth Acquisition
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics
S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09
Smoking Cessation Coverage VA Drug Coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act
H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Wyeth Acquisition
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance
Wyeth Acquisition
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act
H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics
Environmental issues related to pharmaceutical manufacturing
Smoking Cessation Coverage VA Drug Coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics
S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Wyeth Acquisition
S.80 - Pharmaceutic Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act
H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Smoking Cessation Coverage VA Drug Coverage
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics
S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009
Environmental issues related to pharmaceutical manufacturing
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act S. 3325, PL-110-403 (10/13/08) Intellectual Property Enforcement Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
HR. 6432 - Animal Drug User Fee Amendments of 2008. HR. 3161 - Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08
HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
HR. 6432 - Animal Drug User Fee Amendments of 2008. HR. 3161 - Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08
HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Animal Drug User Fee Act Reauthorization - no bill yet. HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07
HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act HR. 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation FY 07 S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Animal Drug User Fee Act Reauthorization - no bill yet. HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) E-Meds Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Veterans Healthcare issues Electronic Prescribing
S. 1547, National Defense Authorization Act for FY 2008 HR. 1585, National Defense Authorization Act for FY 2008 S. 1547, Defense Authorization Act of FY 2008 HR. 1585, Defense Authorization Act of FY 2008
HR. 2206, Veterinarh Workforce Expansion Act of 2005, increased funding for veterinary schools HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S. 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools
HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting
S.Con Res. 21, Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental H. Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation HR. 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006,
HR. 1432, Preserve Access to Affordable Generics Act (settlements) S. 316, Preserve Access to Affordable Generics Act (settlements)
HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007
* Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)